Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Den europeiske union - norsk - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influensavirusoverflateantigener (hemagglutinin og neuraminidase) av stamme a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaksiner - aktiv immunisering mot h5n1 subtype av influensa a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Eletriptan Alternova 20 mg Norge - norsk - Statens legemiddelverk

eletriptan alternova 20 mg

alternova - eletriptanhydrobromid - tablett, filmdrasjert - 20 mg

Eletriptan Alternova 40 mg Norge - norsk - Statens legemiddelverk

eletriptan alternova 40 mg

alternova - eletriptanhydrobromid - tablett, filmdrasjert - 40 mg

Paricalcitol Alternova 1 mikrog Norge - norsk - Statens legemiddelverk

paricalcitol alternova 1 mikrog

alternova a/s - parikalsitol - kapsel, myk - 1 mikrog

Paricalcitol Alternova 2 mikrog Norge - norsk - Statens legemiddelverk

paricalcitol alternova 2 mikrog

alternova a/s - parikalsitol - kapsel, myk - 2 mikrog

Dicloxacillin Alternova 250 mg Norge - norsk - Statens legemiddelverk

dicloxacillin alternova 250 mg

alternova a/s - dikloksacillinnatrium - kapsel, hard - 250 mg

Dicloxacillin Alternova 500 mg Norge - norsk - Statens legemiddelverk

dicloxacillin alternova 500 mg

alternova a/s - dikloksacillinnatrium - kapsel, hard - 500 mg